South Korea · Delayed Price · Currency is KRW Kolon Life Science Statistics
Total Valuation
KOSDAQ:102940 has a market cap or net worth of KRW 607.93 billion. The enterprise value is 722.72 billion.
| Market Cap | 607.93B |
| Enterprise Value | 722.72B |
Important Dates
The next estimated earnings date is Tuesday, March 17, 2026.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:102940 has 12.91 million shares outstanding. The number of shares has increased by 18.03% in one year.
| Current Share Class | 12.91M |
| Shares Outstanding | 12.91M |
| Shares Change (YoY) | +18.03% |
| Shares Change (QoQ) | +14.60% |
| Owned by Insiders (%) | 17.38% |
| Owned by Institutions (%) | 0.25% |
| Float | 7.42M |
Valuation Ratios
The trailing PE ratio is 36.49.
| PE Ratio | 36.49 |
| Forward PE | n/a |
| PS Ratio | 2.88 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 1.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 40.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.92, with an EV/FCF ratio of -50.68.
| EV / Earnings | 40.60 |
| EV / Sales | 3.42 |
| EV / EBITDA | 26.92 |
| EV / EBIT | 42.49 |
| EV / FCF | -50.68 |
Financial Position
The company has a current ratio of 0.56, with a Debt / Equity ratio of 0.35.
| Current Ratio | 0.56 |
| Quick Ratio | 0.24 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 4.56 |
| Debt / FCF | -8.58 |
| Interest Coverage | 2.15 |
Financial Efficiency
Return on equity (ROE) is 7.75% and return on invested capital (ROIC) is 3.06%.
| Return on Equity (ROE) | 7.75% |
| Return on Assets (ROA) | 2.16% |
| Return on Invested Capital (ROIC) | 3.06% |
| Return on Capital Employed (ROCE) | 3.71% |
| Revenue Per Employee | 496.78M |
| Profits Per Employee | 41.88M |
| Employee Count | 322 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.08 |
Taxes
In the past 12 months, KOSDAQ:102940 has paid 329.17 million in taxes.
| Income Tax | 329.17M |
| Effective Tax Rate | 1.82% |
Stock Price Statistics
The stock price has increased by +98.73% in the last 52 weeks. The beta is -0.19, so KOSDAQ:102940's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | +98.73% |
| 50-Day Moving Average | 47,582.00 |
| 200-Day Moving Average | 34,879.75 |
| Relative Strength Index (RSI) | 47.78 |
| Average Volume (20 Days) | 65,712 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:102940 had revenue of KRW 211.13 billion and earned 17.80 billion in profits. Earnings per share was 1,290.73.
| Revenue | 211.13B |
| Gross Profit | 55.77B |
| Operating Income | 17.01B |
| Pretax Income | 18.13B |
| Net Income | 17.80B |
| EBITDA | 26.85B |
| EBIT | 17.01B |
| Earnings Per Share (EPS) | 1,290.73 |
Balance Sheet
The company has 7.57 billion in cash and 122.37 billion in debt, with a net cash position of -114.80 billion or -8,894.28 per share.
| Cash & Cash Equivalents | 7.57B |
| Total Debt | 122.37B |
| Net Cash | -114.80B |
| Net Cash Per Share | -8,894.28 |
| Equity (Book Value) | 346.41B |
| Book Value Per Share | 27,883.86 |
| Working Capital | -81.27B |
Cash Flow
In the last 12 months, operating cash flow was 14.89 billion and capital expenditures -29.15 billion, giving a free cash flow of -14.26 billion.
| Operating Cash Flow | 14.89B |
| Capital Expenditures | -29.15B |
| Free Cash Flow | -14.26B |
| FCF Per Share | -1,104.83 |
Margins
Gross margin is 26.41%, with operating and profit margins of 8.06% and 8.43%.
| Gross Margin | 26.41% |
| Operating Margin | 8.06% |
| Pretax Margin | 8.59% |
| Profit Margin | 8.43% |
| EBITDA Margin | 12.72% |
| EBIT Margin | 8.06% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:102940 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.03% |
| Shareholder Yield | -18.03% |
| Earnings Yield | 2.93% |
| FCF Yield | -2.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KOSDAQ:102940 has an Altman Z-Score of 0.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 5 |